In the initial quarter of 2026, Puig, a prominent player in the beauty sector, saw its revenues climb by 4.7% on a comparable basis, achieving a total of €1.2 billion. This achievement marks a continuation of the company's consistent outperformance in the premium beauty market over the past five years. Jose Manuel Albesa, the CEO appointed in March, highlighted the exceptional results, especially considering the challenging benchmarks set by the fragrance and fashion division, which represents the largest portion of their business. This growth underscores the inherent strength, appeal, and resilience of Puig's diverse portfolio of luxury and specialized brands. While fragrance and fashion contributed a substantial 74% of total revenue with a 3.9% increase, the most dynamic growth was observed in makeup and skincare, which surged by 9.2% and 4.7% respectively. The strong showing in makeup was significantly boosted by Charlotte Tilbury's impressive performance, complemented by steady progress in the skincare sector.
Despite strong financial results, the company's anticipated merger with Estée Lauder Companies remains uncertain. Puig confirmed that no definitive agreement has been reached, emphasizing that assurances regarding the transaction or its terms cannot be provided until a final decision is made. Delving into the category-specific performance, fragrance and fashion generated €896.4 million. The launch of Carolina Herrera’s La Bomba in the US and the double-digit expansion of niche brands like Byredo were key contributors to the fragrance segment. Within its fashion sector, which includes esteemed labels such as Dries Van Noten, Nina Ricci, and Jean Paul Gaultier, the search for a successor to Harris Reed at Nina Ricci is ongoing. Makeup continued to be a standout performer, with revenues reaching €171 million. Charlotte Tilbury's success in the Asia-Pacific and EMEA regions, propelled by popular products like the Airbrush Flawless Blur concealer and Balm Lip Tint, was instrumental. In skincare, the group recorded €147 million in sales, largely due to Uriage’s updated Xemose C8+ line and the strong performance of natural cosmetics brand Apivita. Loto del Sur, a luxury botanical beauty brand, also contributed significantly through its expansion across Latin America.
Geographically, EMEA regions were the primary revenue driver, accounting for 54% of sales at €656 million, with a 3% like-for-like growth, reflecting a measured consumer environment. The Americas contributed 35% of revenue, growing by 2%, while Asia-Pacific displayed remarkable growth of 26.1%, reaching €131 million, largely due to niche fragrances and Charlotte Tilbury's presence. Conversely, the Middle East experienced a 1.2% decline, attributed by the company to the ongoing regional conflict, a trend expected to persist into the next quarter. Despite these challenges, Puig remains optimistic, with CEO Albesa noting a robust pipeline of innovations for the year ahead. The company also underscored its commitment to its teams in the Middle East, prioritizing their safety and commending their resilience amidst the difficult circumstances.
Puig's sustained growth and adaptability in a dynamic global market reflect a forward-thinking business strategy focused on innovation and market responsiveness. By prioritizing both strategic expansion in promising categories like makeup and skincare, and carefully managing geopolitical challenges, the company exemplifies how a well-diversified portfolio and a commitment to employee welfare can drive success. This balanced approach not only ensures financial health but also fosters a resilient and positive corporate culture, setting a benchmark for ethical and sustainable growth in the beauty industry.
